Capital Fund Management (CFM)
DXCM icon

Capital Fund Management (CFM)’s DexCom DXCM Stock Holding History

Capital Fund Management (CFM)’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06M Buy
16,800
+1,200
+8% +$83.6K ﹤0.01% 1659
2025
Q4 		$1.04M Sell
15,600
-21,100
-57% -$1.36M ﹤0.01% 2007
2025
Q3 		$2.47M Sell
36,700
-50,900
-58% -$4.03M 0.01% 1674
2025
Q2 		$7.65M Buy
87,600
+15,700
+22% +$1.23M 0.02% 901
2025
Q1 		$4.91M Sell
71,900
-227,400
-76% -$18.6M 0.01% 1013
2024
Q4 		$23.3M Buy
299,300
+66,400
+29% +$4.92M 0.06% 430
2024
Q3 		$15.6M Buy
232,900
+140,000
+151% +$11.5M 0.04% 546
2024
Q2 		$10.5M Sell
92,900
-74,300
-44% -$9.39M 0.03% 650
2024
Q1 		$23.2M Sell
167,200
-273,900
-62% -$34.4M 0.07% 385
2023
Q4 		$54.7M Buy
441,100
+264,000
+149% +$27M 0.15% 179
2023
Q3 		$16.5M Buy
177,100
+55,400
+46% +$6.25M 0.06% 425
2023
Q2 		$15.6M Buy
+121,700
New +$14.7M 0.06% 404
2023
Q1 		– Sell
-16,700
Closed -$1.89M – 1608
2022
Q4 		$1.89M Sell
16,700
-53,600
-76% -$5.88M 0.01% 958
2022
Q3 		$5.66M Sell
70,300
-3,600
-5% -$305K 0.04% 508
2022
Q2 		$5.51M Buy
+73,900
New +$6.74M 0.05% 488
2020
Q4 		– Sell
-42,400
Closed -$4.37M – 1342
2020
Q3 		$4.37M Buy
+42,400
New +$4.43M 0.05% 387
2019
Q3 		– Sell
-22,000
Closed -$824K – 1711
2019
Q2 		$824K Buy
+22,000
New +$692K 0.01% 1074
2019
Q1 		– Sell
-10,000
Closed -$300K – 1756
2018
Q4 		$300K Sell
10,000
-78,400
-89% -$2.49M ﹤0.01% 1604
2018
Q3 		$3.16M Buy
88,400
+69,200
+360% +$2.15M 0.02% 943
2018
Q2 		$456K Buy
+19,200
New +$407K ﹤0.01% 1634
2015
Q4 		– Sell
-16,400
Closed -$352K – 1592
2015
Q3 		$352K Sell
16,400
-5,200
-24% -$116K ﹤0.01% 1177
2015
Q2 		$432K Buy
+21,600
New +$379K 0.01% 1132

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Fund Management (CFM)'s DXCM Position: Q1 2026 in Review

Capital Fund Management (CFM) increased its DexCom (DXCM) stake by 59% in Q1 2026, buying an estimated $13.7M and bringing the position to 532,396 shares worth $33.4M. The position accounts for 0.15% of the portfolio, ranked #151.

Capital Fund Management (CFM) first reported a position in DXCM in Q1 2014 and has held it in 30 quarters since. The position peaked at $53.8M in Q4 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Capital Fund Management (CFM) held 532,396 shares of DexCom worth $33.4M as of Q1 2026.
  • Capital Fund Management (CFM) bought 197,112 DexCom shares in Q1 2026, an estimated $13.7M.
  • DexCom made up 0.15% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #151 holding.
  • Capital Fund Management (CFM) first reported a position in DexCom in Q1 2014 and has held it in 30 quarters since.
  • Capital Fund Management (CFM)'s DexCom position peaked at $53.8M in Q4 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.